EUVIMEDEUVIMED entdecken
Crossref

Comparison of Intranasal Dexmedetomidine Vs Midazolam for Premedication in Paediatric Patients Undergoing Elective Surgery

Nabanita Roy, Souradeep Chakrabarti

International Journal of Pharmaceutical Quality Assurance · 30.05.2026 · 17 (05)

DOI: 10.25258/ijpqa.17.5.15 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 30.05.2026. Verfasst von Nabanita Roy und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Preoperative anxiety is common in paediatric patients undergoing elective surgery and may adversely affect induction of anaesthesia, parental separation, and postoperative behaviour. Intranasal premedication is widely used due to its non-invasive and easy administration. Midazolam is traditionally used, but dexmedetomidine, an α2-adrenergic agonist, has emerged as an effective alternative with better sedation and anxiolysis and minimal respiratory depression. Aims and Objectives: To compare the efficacy and safety of intranasal dexmedetomidine versus intranasal midazolam as premedication in paediatric patients undergoing elective surgery. Materials and Methods: This prospective, randomized, comparative interventional study was conducted over 1 year at Dinhata Subdivisional Hospital, Coochbehar on 100 paediatric patients undergoing elective surgery under general anaesthesia. Patients were randomly assigned to receive either intranasal dexmedetomidine or midazolam, and outcomes including sedation, parental separation, mask acceptance, and adverse effects were compared.

Results

Baseline characteristics were comparable (age p = 0.912, gender p = 0.841). Dexmedetomidine showed significantly higher sedation scores at 30 min (3.80 ± 0.72 vs 3.10 ± 0.69) and 45 min (4.20 ± 0.55 vs 3.60 ± 0.60; p < 0.001), better parental separation (76% vs 50%; p = 0.018), and improved mask acceptance (72% vs 44%; p = 0.021), with fewer adverse effects overall (p = 0.014).

Conclusion

Intranasal dexmedetomidine is more effective than intranasal midazolam in providing sedation, anxiolysis, and smoother induction conditions in paediatric patients undergoing elective surgery, with a comparable safety profile. It can be considered a superior alternative for premedication in this population.

Zitieren

APA

Roy, N., & Chakrabarti, S. (2026). Comparison of Intranasal Dexmedetomidine Vs Midazolam for Premedication in Paediatric Patients Undergoing Elective Surgery. International Journal of Pharmaceutical Quality Assurance, 17(05). https://doi.org/10.25258/ijpqa.17.5.15

Vancouver

Roy N, Chakrabarti S. Comparison of Intranasal Dexmedetomidine Vs Midazolam for Premedication in Paediatric Patients Undergoing Elective Surgery. International Journal of Pharmaceutical Quality Assurance. 2026;17(05). doi:10.25258/ijpqa.17.5.15

BibTeX
@article{Roy2026,
  author = {Roy, Nabanita and Chakrabarti, Souradeep},
  title = {Comparison of Intranasal Dexmedetomidine Vs Midazolam for Premedication in Paediatric Patients Undergoing Elective Surgery},
  journal = {International Journal of Pharmaceutical Quality Assurance},
  year = {2026},
  volume = {17},
  number = {05},
  doi = {10.25258/ijpqa.17.5.15}
}
Kostenlos starten →